Coleman R E
Duke University Medical Center, Box 3949, Durham, North Carolina 27710, USA.
Nucl Med Biol. 2000 Oct;27(7):689-90. doi: 10.1016/s0969-8051(00)00139-6.
F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging is being increasingly utilized in the detection of malignancy and in following the effects of therapy. FDG-PET imaging has been demonstrated to be accurate in the diagnosis of several malignancies including lung cancer, lymphoma, recurrent colorectal cancer, and recurrent melanoma. The initial studies evaluating FDG-PET in determining the effect of therapy reveal promising results. The clinical images are interpreted subjectively like other clinical nuclear medicine imaging studies. Semiquantitative indices such as the standardized uptake value may be used for research purposes to provide a quantitative parameter from the study.
F-18氟脱氧葡萄糖正电子发射断层扫描（FDG-PET）成像在恶性肿瘤检测及追踪治疗效果方面的应用越来越广泛。FDG-PET成像已被证明在诊断包括肺癌、淋巴瘤、复发性结直肠癌和复发性黑色素瘤在内的多种恶性肿瘤时具有准确性。评估FDG-PET在确定治疗效果方面的初步研究显示出有前景的结果。临床图像与其他临床核医学成像研究一样通过主观方式解读。诸如标准化摄取值等半定量指标可用于研究目的，以便从研究中提供一个定量参数。
